10QSB 1 flx06q3e

0001548123-17-000267.txt : 20171114 0001548123-17-000267.hdr.sgml : 20171114 20171114160326 ACCESSION NUMBER: 0001548123-17-000267 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 42 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171114 DATE AS OF CHANGE: 20171114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLEXPOINT SENSOR SYSTEMS INC CENTRAL INDEX KEY: 0000925660 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 870620425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-24368 FILM NUMBER: 171201384 BUSINESS ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 BUSINESS PHONE: 8015685111 MAIL ADDRESS: STREET 1: 106 W. BUSINESS PARK DRIVE CITY: DRAPER STATE: UT ZIP: 84020 FORMER COMPANY: FORMER CONFORMED NAME: MICROPOINT INC DATE OF NAME CHANGE: 19980424 FORMER COMPANY: FORMER CONFORMED NAME: NANOTECH CORP DATE OF NAME CHANGE: 19940620 10-Q 1 flxt10qq32017v85.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2017 10QSB 1 flx06q3e

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For quarterly period ended September 30, 2017

[ ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission file number: No. 0-24368

FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)


Delaware	87-0620425
(State of incorporation)	(I.R.S. Employer Identification No.)

106 West 12200 South, Draper, Utah 84020

(Address of principal executive offices)

801-568-5111

(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ X ] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]

Non-accelerated filer [ ]

Accelerated filer [ ]

Smaller reporting company [X]

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [ ] No [X]

The number of shares outstanding of the registrant’s common stock was 78,363,464 as of November 14, 2017.

TABLE OF CONTENTS

PART I: FINANCIAL INFORMATION


Item 1.	Condensed Financial Statements

	Condensed Consolidated Balance Sheets (Unaudited) at September 30, 2017 and		3
		December 31, 2016

	Condensed Consolidated Statements of Operations (Unaudited) for the Three		4
		And Nine Months Ended September 30, 2017 and 2016

	Condensed Consolidated Statements of Cash Flows (Unaudited) for the		5
		Nine Months Ended September 30, 2017 and 2016

	Notes to Condensed Consolidated Financial Statements (Unaudited)		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		13

Item 3.	Quantitative and Qualitative Disclosure about Market Risk		18

Item 4.	Controls and Procedures		18

PART II: OTHER INFORMATION


Item 1.	Legal Proceedings	19

Item 1A.	Risk Factors	19

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20

Item 3.	Defaults upon Senior Securities	20

Item 4	Mine Safety Disclosures	20

Item 5.	Other Information	20

Item 6.	Exhibits	21

Signatures		22

PART I - FINANCIAL INFORMATION

ITEM 1. CONDENSED FINANCIAL STATEMENTS

The financial information set forth below with respect to our condensed consolidated financial position as of September 30, 2017, the condensed consolidated statements of operations for the three and nine months ended September 30, 2017 and 2016, and cash flows for the nine months ended September 30, 2017 and 2016 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2016 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on April 18, 2017. The results of operations for the three and nine months ended September 30, 2017 and 2016, respectively, are not necessarily indicative of results to be expected for any subsequent periods.

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS


	September 30, 2017 (Unaudited)	December 31, 2016
ASSETS
Current Assets
Cash and cash equivalents	$ 11,061	$ --
Accounts receivable, net of allowance for bad debts of $102,140 and $102,140	86,914	84,499
Deposits, prepaid expenses, and other current assets	11,383	9,348
Total Current Assets	109,358	93,847
Long-Term Deposits	6,550	6,550
Property and Equipment, net of accumulated depreciation
of $588,446 and $586,787	9,144	10,823
Patents and Proprietary Technology, net of accumulated
amortization of $915,724 and $876,037	58,321	96,358
Goodwill	4,896,917	4,896,917
Total Assets	$ 5,080,290	$ 5,104,495

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable	$ 212,946	$ 172,602
Accounts payable - related party	--	1,420
Accrued liabilities	1,008,986	741,778
Due to related parties	54,513	--
Convertible notes payable, net	1,420,173	1,184,660
Convertible notes payable to related party, net	37,523	20,000
Derivative liabilities	126,630	76,295
Total current liabilities	2,860,771	2,196,755
Long-term Liabilities
Convertible notes payable to related party, net	9,792	--
Total Liabilities	2,870,563	2,196,755

Stockholders' Equity
Preferred stock – $0.001 par value; 1,000,000 shares authorized;
no shares issued or outstanding	-	-
Common stock – $0.001 par value; 100,000,000 shares authorized;
78,363,464 shares and 78,363,464 shares issued and outstanding	78,363	78,363
Additional paid-in capital	29,067,104	29,052,188
Accumulated deficit	(26,935,740)	(26,222,811)
Total Stockholders' Equity	2,209,727	2,907,740
Total Liabilities and Stockholders' Equity	$ 5,080,290	$ 5,104,495

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


		For the Three Months		For the Nine Months
		Ended September 30,		Ended September 30,
	2017		2016	2017	2016

Design, Contract and Testing Revenue		$ 40,622	$ 104,364	$ 256,323	$ 232,569

Operating Costs and Expenses
Amortization of patents and proprietary
proprietary technology		9,154	18,423	39,687	64,510
Cost of revenue		8,503	13,859	43,144	16,369
Administrative and marketing expense		160,769	171,888	515,620	525,245
Research and development expense		79,975	81,715	244,484	241,055

Total Operating Costs and Expenses		258,401	285,885	842,935	847,179

Net Operating Loss		(217,779)	(181,521)	(586,612)	(614,610)

Other Income and Expenses
Interest expense		(73,197)	(266,180)	(238,537)	(720,777)
Interest income		12	1,916	35	5,746
Gain on derivative		63,006	--	112,185	--

Net Other Income (Expense)		(10,179)	(264,264)	(126,317)	(715,031)

Net Loss		$ (227,958)	$ (445,785)	$ (712,929)	$ (1,329,641)

Basic and Diluted Loss per Common Share		$ (0.00)	$ (0.01)	$ (0.01)	$ (0.02)

Basic and Diluted Weighted-Average
Common Shares Outstanding		78,363,464	71,712,536	78,363,464	71,656,107

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)



	For the Nine Months
	Ended September 30,
	2017	2016
Cash Flows from Operating Activities:
Net loss	$ (712,929)	$ (1,329,641)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock subscription for compensation	--	1,000
Stock-based compensation expense	14,916	25,295
Amortization of patents and proprietary technology	39,687	64,510
Amortization of discount on note payable	22,049	641,865
Depreciation	1,679	--
Change in fair value of derivative liabilities	(112,185)	--
Interest expense recognized for derivative liabilities	63,298	--
Changes in operating assets and liabilities:
Accounts receivable	(2,415)	(124,775)
Deposits and prepaid expenses	(2,034)	2,613
Accounts payable	40,344	29,253
Accounts payable – related parties	(1,420)	2,159
Accrued liabilities	336,342	273,121
Net Cash Used in Operating Activities	(312,668)	(414,600)

Cash Flows from Investing Activities:
Purchase of proprietary technology	(1,650)
Note receivable interest income	--	(5,711)
Net Cash Used in Investing Activities	(1,650)	(5,711)
Cash Flows from Financing Activities:
Repayment of bank overdrafts	(14,621)	--
Proceeds from borrowings under convertible note payable – related party	47,000	--
Repayment of borrowings under convertible note payable – related party	(7,000)	20,000
Proceeds from borrowings under convertible note payable	300,000	380,000
Net Cash Provided by Financing Activities	325,379	400,000

Net Change in Cash and Cash Equivalents	11,061	(20,311)
Cash and Cash Equivalents at Beginning of Period	--	22,706
Cash and Cash Equivalents at End of Period	$ 11,061	$ 2,395

Supplemental Cash Flow Information:
Cash paid for income taxes	$ --	$ --
Cash paid for interest	$ --	$ --
Supplemental Disclosure on Noncash Investing and Financing Activities
Recognition of discounts on convertible notes payable	$ 99,221	$ 124,340
Stock issued for subscription payable	$ --	$ 10,958
Assumption of liabilities by related parties	$ 54,513	$ --

The accompanying notes are an integral part of these condensed consolidated financial statements

FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1– SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.

Nature of Operations – Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through September 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.

Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.

Fair Value Measurements - The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk.

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value

hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

The carrying value of the Company’s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.

Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and production generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. The balance in the allowance account was $102,140 and $102,140 in the periods ended September 30, 2017 and December 31, 2016, respectively.

Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.

Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.

Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.

Research and Development – Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.

Goodwill – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.

Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts

are met and then recognized as licensing royalty revenue over the remaining term of the contracts. The Company does not provide extended warranties or guarantees on its products.

Stock-Based Compensation – The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended September 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $14,916 and $25,295, respectively.

Basic and Diluted Loss Per Share – Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2017 and September 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 30,903,567 and 24,459,697, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.

Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. During the nine-month period ended September 30, 2017, a customer who manufacturers gloves containing our sensors represented 18% of sales and represented 16% of accounts receivable. The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.

Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized.

Recent Accounting Pronouncements – In August 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815).” The new standard amends the hedge accounting recognition and presentation requirements in ASC 815. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adopting the new guidance as well as the impact it may have on its consolidated financial statements.

The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

NOTE 2 – GOING CONCERN

The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,935,740 at September 30, 2017. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. The Company has relied on raising additional capital through the issuance of convertible notes payable; however, there is no assurance that additional funding will be available on acceptable terms, if at all.

NOTE 3 – DERIVATIVE INSTRUMENTS

The derivative liability as of September 30, 2017, in the amount of $126,630 has a Level 3 fair value classification.

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2017 and December 31, 2016:


	Total
Balance, December 31, 2015		-
Recognition of derivative liabilities upon initial valuation		40,892
Change in fair value of derivative liabilities		35,403
Conversions of derivative liabilities into equity instruments		-
Balance, December 31, 2016		76,295
Recognition of derivative liabilities upon initial valuation		162,520
Change in fair value of derivative liabilities		(112,185)
Conversions of derivative liabilities into equity instruments		-
Balance, September 30, 2017		126,630

During the year ended 2016 and the period ended September 30, 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Company’s lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.

At September 30, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $126,630. The Company recorded a gain from change in fair value of derivatives of $112,185 for the nine month period ended September 30, 2017. During the nine months ended September 30, 2017, the Company recorded additional interest expense of $63,298 and debt discounts of $99,221 in connection with the recognition of derivative liabilities. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 81.33% to 118.34%, (3) weighted average risk-free interest rate of 1.06% to 1.31% (4) expected life of 0.25 to 1.25 years, and (5) the quoted market price of the Company’s common stock at each valuation date.

In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.

As of September 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:


	Level 1		Level 2		Level 3		Total
Derivative Liabilities		-		-		126,630		126,630
Total	$	-	$	-	$	126,630	$	126,630

Convertible Notes Payable

During 2015 the Company secured additional financing to cover its ongoing operations in the amount of $590,000 by issuing various convertible notes bearing 10% annual interest (15% default interest), secured by business assets and carrying exercise prices ranging between $0.025 and $0.07 per share. Additionally, during 2015 the Company issued $51,000 for a non-convertible note payable bearing 10% annual interest (15% default interest) and secured by the $51,157 note receivable held by the Company (see Note 2). During 2015, all of these notes (both convertible and non-convertible issued in 2014 and 2015) and accrued interest were either converted into common stock or extinguished and consolidated into two remaining convertible notes payable to two investors in principal amounts of $684,660 and $123,797 (with respective maturity dates of December 31, 2016 and November 30, 2016). Both notes are convertible at $0.05 per share, bear 10% annual interest rates (15% default interest) and are secured by business assets. During 2016 the Company approved the conversion of the convertible note payable in the amount of $123,797 into 2.7 million shares of common stock. As of September 30, 2017, the principle balance of the convertible note payable in the amount of $684,660 remains outstanding.

The Company entered into a new promissory note for up to $300,000 from a third party on May 25, 2017. The note has an annual interest rate of 10% and is secured by the Company’s equipment. The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018. The Company drew $40,000 against that note on June 2, 2017, $40,000 on July 13, 2017, $40,000 on August 14, 2017 and $40,000 on September 22, 2017.

The Company entered into a convertible promissory note for up to $300,000 from a third party on July 1, 2016. The note has an annual interest rate of 10% and is secured by the Company’s equipment. The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016. The Company drew $160,000 against that note during 2016 and $40,000 on January 6, 2017; $40,000 on January 31, 2017 $40,000 on March 7, 2017 and the balance of $20,000 on April 28, 2017.

On August 8, 2011, the Company entered into a convertible note payable with a former Company Director for $40,000. This note was due on December 31, 2015, bears an annual interest rate of 10% annual interest and is secured by business equipment.

Convertible Note Payable Related Party

On September 1, 2017 the Company issued a note for $10,000 to an officer of the Company. The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2018. The note is secured by all of the Company’s business equipment.

On August 2, 2017 the Company issued a note for $10,000 to an officer of the Company. The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2017. The note is secured by all of the Company’s business equipment.

On July 12, 2017, an officer of the Company provided $7,000 to the Company under a line of credit. On September 23, 2017 the Company paid $7,000 to fully retire that obligation.

On April 17, 2017 the Company issued a note for $20,000 to an officer of the Company. The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2018. The note is secured by all of the Company’s business equipment.

On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company. The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016. Since the fair value of the common stock at the date of the July 1, 2016 advance was $0.07, no BCF was recorded.

NOTE 4 – STOCK OPTION PLANS

On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated. This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company’s trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent. The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.

On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company’s common stock. Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month

period in equal installments on the last day of 2015, 2016 and 2017, respectively. We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.

Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options. Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share. The options vest over three years and expire 10 years from the date of grant. The Company used the following assumptions in estimating the fair value of the options granted:

Market value at the time of issuance – Range of $0.14 to 2.07

Expected term – Range of 3.7 years to 10.0 years

Risk-free interest rate – Range of 1.60% to 4.93%

Dividend yield – 0%

Expected volatility – 200% to 424%

Weighted-average fair value - $0.16 to $2.07

During the nine months ended September 30, 2017, the Company recognized a total of $14,916 of stock-based compensation expense, leaving $3,153 in unrecognized expense as of September 30, 2017. During the nine months ended September 30, 2016, the Company recognized $25,295 in stock-based compensation expense. There were 2,185,000 and 2,185,000 employee stock options outstanding at September 30, 2017 and December 31, 2016, respectively.

A summary of all employee options outstanding and exercisable under the plan as of September 30, 2017, and changes during the three months then ended is set forth below:


Options	Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$ 0.16	8.66	$ --
Granted	--	--	--	--
Expired	--	--	--	--
Forfeited	--	--	--	--
Outstanding at the end of Period	2,185,000	$ 0.17	7.91	$ --
Exercisable at the end of Period	1,836,667	$ 0.17	7.91	$ --

NOTE 5 – CAPITAL STOCK

Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At September 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding.

Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. No shares of stock were issued during the nine months ended September 30, 2017.

NOTE 6 - COMMITMENTS AND CONTINGENCIES

The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. Either party may terminate the lease upon 90 day written notice. Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017.

NOTE 7 – RELATED PARTY TRANSACTIONS

At September 30, 2017 and December 31, 2016, the Company had accounts payable of $-0- and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.

During the period an Officer of the Company and Director of the Company assumed a total of $54,513 in accrued liabilities owed by the Company. The Company recorded the amount assumed as a due to related party on the balance sheet in the amount of $54,513 as of September 30, 2017. The amounts due to both the Officer and Director accrue interest at 8%, have a conversion feature for restricted common shares at $0.07 per share and must be repaid by December 31, 2018.

NOTE 8 - SUBSEQUENT EVENTS

On November 1, 2017 the Company received a short-term loan in the amount of $20,000 from an officer of the Company. The Company intends to repay the loan when funds are available. No terms have been established for this loan at the date of this filing.

On November 9, 2017 the Company authorized the conversion of promissory notes totaling $160,000 and accrued interest in the amount of $40,000 through the issuance of 4,000,000 shares of its restricted common stock. The conversion rate was $0.05 per share, pursuant to the terms of the convertible note agreements. The stock has not been issued as of the date of this filing.

In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our” refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.

FORWARD LOOKING STATEMENTS

The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions. This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

Flexpoint Sensor Systems, Inc. is principally engaged in designing, engineering and manufacturing bend sensor technology and products using Bend Sensor^® technology, (a flexible potentiometer technology). We continue to make further improvements to our technologies, manufacturing and developing fully integrated devices and related products that we have been marketing and selling to a variety of companies in diverse industries. We are negotiating and signing agreements and contracts that have provided some limited revenues and have proven that our sensors are more durable, adaptable and cost effective than any other product currently on the market. We own five patents, including patents on specific devices that use the Bend Sensor^® and have exclusive rights through licensing agreements to other patents and devices.

We are continuing to develop and enhance our intellectual properties that will result in additional patents being filed. The Company currently manufactures, and has jointly developed, eighteen products that are being sold and supplied to current customers and we continue to receive orders for custom prototype sensors as well as our standard sensors. During 2017 we have focused our marketing efforts on a number of larger domestic and international companies that have applications which have the potential to greatly increase the volume of sensors we are currently manufacturing.

At September 30, 2017 the Company had at least sixteen global commercial partners covering a variety of different products. In coordination with its partners, the Company introduced at least eight new products during 2017 and expects to have two to three more commercialized prior to the end of the year; including the product launch of a wearable shoe application expected to take place in Europe and the product launch in North America of a medical orthotics shoe product. Management believes this growth in sales channels will allow the Company to grow at an increasingly accelerated rate over the next several quarters.

Our sales and marketing efforts have been targeted toward the development of new relationships with clients while maintaining and strengthening relationships already developed with several Tier 1 (major) suppliers in the automotive industry. We have built and shipped orders to a number of these companies to enable them to test the utilization of our sensors into their existing and developing product lines.

The Company continues to develop relationships in a number of application fields. In July we announced a strategic relationship with HTK Safety to begin offering an integrated safety system utilizing the Bend Sensor^® technology. In March 2017 we announced a collaborative working arrangement with 11 Health and Technologies Inc. to develop next generation products in the medical industry. Flexpoint has also established relationships with several other medical IoT vendors. These include companies like 11Health, Neofect, Gloreha and YouReHab; all with a focus on medical rehabilitation with a different approach. Products from these companies range from gloves to prosthetics to virtual reality, all with the intention of improving medical health or medical rehab. Medical IoT sensor volume is expected to be more than 50,000 sensors in 2017.

In March 2017 we announced a collaborative relationship with CaptoGlove, a company which manufactures a wearable virtual reality gaming motion controller. Our companies will work together to deliver innovative, integrated virtual reality/augmented reality (“VR/AR”) systems to mass markets. We completed and shipped the initial portion of the order before the end of the second quarter and expect to complete and ship the entire order early next year. Their ground-breaking glove systems, combined with unique, leading edge software applications, also adapt to a wide range or other applications, including health rehabilitation, unmanned systems control, smartphone interaction and professional training across multiple industries.

ManusVR, CaptoGlove and Virtual Motion Labs have products that are currently commercially available and feature the Flexpoint Bend Sensor®. A few other companies in this market are expected to release Bend Sensor® products in 2017. Flexpoint expects the purchase orders that are currently being fulfilled for ManusVR and CaptoGlove to significantly ramp up in volume and frequency throughout 2017 and early 2018. Flexpoint has received orders for more than 150,000 sensors and related assemblies from multiple development partners around the globe. The Company began to fulfill the orders in the second quarter of 2017 and complete fulfillment is expected by early next year. Based upon the increased orders, management expects significant revenue growth within the next six to twelve months. Demand continues to grow and the Company expects to receive increasingly larger volume orders before year end and continuing into 2018.

The Company began selling and distributing sensors through two resellers in 2016. Flexpoint has since greatly increased its relationships with resellers and is currently working with seven resellers across diverse industries. Some of these companies include Amazon, NoDNA, RobotShop, Karlsson Robotics, SPI and Infusion Systems. We are receiving recurring sales from these resellers with most experiencing a growing number of sensors ordered each time. We anticipate that sensor volume sold in 2017 through these channels should approach 25,000.

The biggest revenue contributors during the 2017 nine month period were for glove based products and the toy relationship. Flexpoint, year-to-date, has delivered on approximately 200,000 sensors for its partnership with the toy manufacturer. The Company expects annualized volumes for 2017 to be approximately a half a million sensors. Sensor volume from glove based applications is expected to exceed 175,000 in 2017.

In October the Company made announcements relating to two of its partners. The first announced the receipt of additional production orders from global market virtual reality leader Manus VR, which brought to market the industry’s first fully functional virtual reality glove. The possibilities and applications for these gloves extend far beyond the virtual reality market, which Goldman Sachs estimates will be an $80 billion market by 2025.

The second October announcement relates to the commercialization by Focal Wellness of wearable devices developed through a collaborative design relationship with the Company. The initial product offering will be a wearable glove/sleeve targeted to people suffering from carpal tunnel syndrome. The wearable device measures and monitors the individual’s wrist position using our Bend Sensor®.

Our patented technology continues to gain recognition in various markets and industries as evidenced by orders from a Fortune 100 automotive maker for our horn system. Although, so far the volumes for our applications and devises have been relatively small we continue to receive follow up orders for the universal sensor that we jointly developed. We expect to receive additional orders from other customers for this sensor as it becomes more recognizable in the market. Currently our customers for this type of sensor include companies in the following industries: automobiles, trucking, emergency vehicles, public transportation, military and other governmental entities. As anticipated, the Company is beginning to see the potential for more significant volumes and revenues from the sale of this sensing devise over the next year and beyond.

Finalizing additional long-term revenue generating production contracts with other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to, and are dependent upon, our ability to attract significant long-term production contracts. In the short term, we must continue to obtain funding to operate and expand our operations so that we can deliver our unique Bend Sensor^® and Bend Sensor^® related technologies and products to the market. Management believes we will become cash flow positive by or before 2018 first quarter; however, it is likely that significant progress may be delayed for the next six to nine months, primarily due to the time it takes for negotiating such contracts. Accordingly, we cannot guarantee that we will realize significant revenues or that we will become profitable over the next six to nine months.

LIQUIDITY AND CAPITAL RESOURCES

Currently our revenue is primarily from design contract, testing services for prototypes and samples, and limited production and is not to a level to support our operations. For the past twelve months we have relied on the proceeds of convertible loans from existing shareholders and private placements of our common stock. However, we believe, based upon current orders and projected orders over the next twelve months, that we could be producing sensors under long-term contracts that will help support our existing operations and potential future growth. Management recognizes such contracts usually go through a long negotiation process and there can be no guarantee that we will be successful in our negotiations or that such contracts will be sufficient to support our current operations in the near future.

Management believes that our current cash burn rate is approximately $75,000 per month and the proceeds from the convertible notes and our manufacturing, engineering and design fees will not totally fund our anticipated growth in operations. We will therefore need to raise additional financing. We believe that this additional financing will provide the needed capital to extend operations to the development and production of our growing product offerings and growing manufacturing opportunities. However, we may not be able to obtain financing, or the sources of financing, if any, may not continue to be available, and if available, they may be on terms unfavorable to us.

We also expect that in the short term we may have to continue to issue common stock to pay for services and agreements rather than use our limited cash resources. Any issuance of common stock will likely be pursuant to exemptions provided by federal and state securities laws. The purchasers and manner of issuance will be determined according to our financial needs and the available exemptions. We also note that if we issue more shares of our common stock our shareholders may experience dilution in the value per share of their common stock.

As we enter into production and development agreements, we must ensure that those agreements provide adequate funding for any pre-production research and manufacturing costs. As we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or royalties related to these agreements. However, we have formalized only a few agreements during the past four years and there can be no assurance that the agreements will generate sufficient revenues or be profitable in the future or that a desired technological application will be successful enough to produce the volumes and profits necessary to fund our operations.

FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES

Our principal commitments at September 30, 2017 consisted of our operating lease of $9,600 per month, and total liabilities of $2,870,563, which includes $1,467,488 of convertible notes payable, net of debt discounts. Accrued liabilities at September 30, 2017, were $1,008,986 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.

During the nine months ending September 30, 2017, the Company has raised an additional $340,000 in operating capital through the issuance of short-term notes. The notes have an annual interest rate of 8% to 10% and a default rate of 12% to 15% annually. The notes, which total $1,544,660 (excluding debt discounts), are secured by the Company’s business equipment and have a conversion feature for restricted common shares at $0.05 to $0.07 per share.

On November 9, 2017 the Company authorized yet to be issued shares of common stock to Empire Fund Managers. The Company will issue 4,000,000 shares of restricted common stock at an average price of $0.05 per share in full settlement of promissory notes and accrued interest totaling $200,000.

MAJOR CUSTOMER

The Company has a major customer which is an American-based, Fortune 500, global toy manufacturing company which it supplies through its global assembly partner who represents a significant portion of revenue and accounts receivable. During the nine months ended September 30, 2017, the customer represented 18% of sales and represents 16% of accounts receivable at September 30, 2017. The Company has a strong ongoing relationship with

this customer with scheduled deliveries extending through the year and does not believe this concentration poses a significant risk, as apportion of the control for their products is based on the Company’s technologies.

OFF-BALANCE SHEET ARRANGEMENTS

Other than our current operating lease, we have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

CRITICAL ACCOUNTING ESTIMATES

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.

The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized, therefore we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its nets assets. The test requires various judgments and estimates. During 2016 and for the nine months ending September 30, 2017, the Company recorded no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing performed at December 31, 2016, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets which has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment.

We test long-lived assets for impairment annually or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long-lived assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Impairment tests are conducted on an annual basis and, should they indicate a carrying value in excess of fair value, a charge may be required.

Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. Also, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate. Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the nine month periods ended September 30, 2017 and 2016 we recognized $14,916 and $25,295, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.

RESULTS OF OPERATIONS

The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and should be read in conjunction with our unaudited financial statements for the three and nine months ended September 30, 2017 and 2016, included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2016 and 2015.

THREE MONTH PERIOD ENDED SEPTEMBER 30, 2017:


SUMMARY OF OPERATING RESULTS
	Three month period ended
	September 30, 2017	September 30, 2016
Design, contract and testing revenue	$ 40,622	$ 104,364
Total operating costs and expenses	258,401	285,885
Net other income (expense)	(134,649)	(264,264)
Net loss	(227,958)	(445,785)
Basic and diluted loss per common share	(0.00)	(0.01)

For the three months ending September 30, 2017 revenue was $40,622, a $63,742 decrease when compared to the same period in 2016. The majority of the revenue for this period came from production of products. The Company continues to concentrate its marketing resources on a limited number of customers that have the greatest potential to generate the most short-term revenue while still building relationships with our larger customers. Management believes this approach has the highest potential to bring long-term commercially viable products to market and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations. Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering. However, until a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations. Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.

We received revenue from repeat orders from our existing customers, design contract, and development engineering. Revenue from the sale of a product is recorded at the time of shipment to the customer. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract.

Of the $258,401 and $285,885 total operating costs and expense for the three months ending September 30, 2017 and 2016, respectively, $79,975 and $81,715 were for direct research and development cost, respectively. For the three months ended September 30, 2017, total operating expenses decreased by $27,484 when compared to the same period in 2016, due primarily to decreased cost of revenues related to lower revenue and a reduction of amortization expense due to the fully amortized status of some intellectual property.

Other expense for the three month period ended September 30, 2017 was $10,179, a $254,085 decrease compared to the same period in 2016. The decrease is attributable primarily to the difference in beneficial conversion charges on the convertible notes in 2017 versus 2016, in addition to a gain on derivative recorded in 2017.

A net loss of $227,958 was realized for the three months ended September 30, 2017. A net loss of $445,785 was realized for the three month period ended September 30, 2016.

NINE MONTH PERIOD ENDED SEPTEMBER 30, 2017:


SUMMARY OF OPERATING RESULTS
	Nine month period ended
	September 30, 2017	September 30, 2016
Design, contract and testing revenue	$ 256,323	$ 232,569
Total operating costs and expenses	842,935	847,179
Net other income (expense)	(126,317)	(715,031)
Net loss	(712,929)	(1,329,641)
Basic and diluted loss per common share	(0.01)	(0.02)

For the nine months ending September 30, 2017 revenue was $256,323, a $23,754 increase when compared to the same period in 2016. The majority of the revenue for this period came from production products. Management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering.

Of the $842,935 and $847,179 total operating costs and expense for the nine months ending September 30, 2017 and 2016, respectively, $244,484 and $241,055 were for direct research and development cost, respectively. For the nine months ended September 30, 2017, total operating expenses decreased by $4,244 when compared to the same period in 2016, due primarily to decreases in amortization charges on intellectual property.

Other expense for the nine month period ended September 30, 2017 was $126,317, a $588,714 decrease compared to the same period in 2016. The decrease is attributable primarily to the difference in beneficial conversion charges on the convertible notes in 2017 versus 2016, offset in part by the gain on derivative valuation.

A net loss of $712,929 was realized for the nine months ended September 30, 2017. A net loss of $1,329,641 was realized for the nine month period ended September 30, 2016.

The chart below represents a summary of our condensed consolidated balance sheets at September 30, 2017 and December 31, 2016.


SUMMARY OF BALANCE SHEET INFORMATION

	September 30, 2017	December 31, 2016
Cash and cash equivalents	$ 11,061	$ --
Total current assets	109,358	93,847
Total assets	5,080,290	5,104,495
Total liabilities	2,870,563	2,196,755
Deficit accumulated	(26,935,740)	(26,222,811)
Total stockholder’s equity	$ 2,209,727	$ 2,907,740

Cash and cash equivalents increased by $11,061 at September 30, 2017 compared to December 31, 2016. The increase in cash is due to the timing of payment of expenses, collection of accounts receivable and proceeds from borrowings. Our non-current assets decreased at September 30, 2017 due to the amortization of long-lived assets.

Total liabilities increased by $673,808 at September 30, 2017. The increase was due primarily to the funding of operations through the issuance of convertible notes payable, the accrued interest related to those notes, accruals for investor relations and insurance expenses and an increase in the derivative liabilities.

INFLATION

We do not expect the impact of inflation on our operations to be significant for the next twelve months.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

(a)

Disclosure Controls and Procedures

As of the end of the period covered by this quarterly report we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of our disclosure controls and procedures. Our controls and procedures are designed to allow information required to be disclosed in our reports to be recorded, processed, summarized and reported within the specified periods, and

accumulated and communicated to management to allow for timely decisions regarding required disclosure of material information. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Based upon the evaluation, our Chief Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures were not effective at that reasonable assurance level as of the end of the period September 30, 2017.

The material weaknesses relate to the limited number of persons responsible for the recording and reporting of financial information, the lack of separation of financial reporting duties, and the limited size of our management team in general. We are in the process of evaluating methods of improving our internal control over financial reporting, including the possible addition of financial reporting staff and the increased separation of financial reporting responsibility, and intend to implement such steps as are necessary and possible to correct these material weaknesses.

(b)

Changes in Internal Control over Financial Reporting

There have been no changes in internal control over financial reporting during the quarter ended September 30, 2017

that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

We have a history of losses and may never become profitable.

We are unable to fund our day-to-day operations from revenues and the lack of revenues for continued growth may cause us to delay our business development. For the nine months ending September 30, 2017, we had negative cash flows from operating activities of $312,668. We will require additional financing to fund our short-term cash needs and we may be required to rely on debt financing, loans from related parties, and private placements of our common stock for that additional funding. Such funding sources may not be available or the terms of such funding sources may not be acceptable to the company. If the Company is unable to find such funding it could have a material adverse effect on our ability to continue as a going concern.

We may not have adequate resources to successfully manage anticipated growth.

We may not be equipped to successfully manage any possible future periods of rapid growth or expansion, which could be expected to place a significant strain on our managerial, operating, financial and other resources. Our future performance will depend, in part, on our ability to manage growth effectively, which will require us to:

improve existing, and implement new, financial controls and systems, management information systems, operating, administrative, financial and accounting systems and controls,

maintain close coordination between engineering, programming, accounting, finance, marketing, sales and operations, and

attract and retain additional qualified technical and marketing personnel.

There is intense competition for management, technical and marketing personnel in our business. The loss of the services of any of our key employees or our failure to attract and retain additional key employees could have a material adverse effect on our ability to continue as a going concern.

Our success is dependent on our intellectual property rights which are difficult to protect.

Our future success depends on our ability to protect our intellectual property. We use a combination of patents and other intellectual property arrangements to protect our intellectual property. There can be no assurance that the

protection provided by our patents will be broad enough to prevent competitors from introducing similar products or that our patents, if challenged, will be upheld by courts of any jurisdiction. Patent infringement litigation, either to enforce patents or defend ourselves from infringement suits, will be expensive and could divert our resources from other planned uses. Patent applications filed in foreign countries and patents in these countries are subject to laws and procedures that differ from those in the U.S. and may not be as favorable to us. We also attempt to protect our confidential information through the use of confidentiality agreements and by limiting access to our facilities. There can be no assurance that our program of patents, confidentiality agreements and restricted access to our facilities will be sufficient to protect our confidential information and intellectual properties from our competitors.

Research and development may result in problems which may become insurmountable to full implementation of production.

Customers request that we create prototypes and perform pre-production research and development. As a result, we are exposed to the risk that we may find problems in our designs that are insurmountable to fulfill production. In that event, we would be unable to recover the costs of the pre-production research and development. However, we are currently unaware of any insurmountable problems with ongoing research and development that may prevent further development of an application.

Because we are significantly smaller than the majority of our competitors, we may lack the financial resources needed to capture increased market share.

The market for sensor devices is extremely competitive, and we expect that competition will intensify in the future. There can be no assurance that we will be able to compete successfully against current or future competitors or that competitive pressures we face will not materially adversely affect our business, operating results or financial condition. Our primary competitors in the VR/AR market are Interlink Electronics and manufacturers of accelerometers and IMU’s, (Inertial Measurement Units). Our Primary competitors in the air bag market are International Electronics and Engineering, Siemens, Robert Bosch GmbH, Denso, Inc., Breed Technologies, TRW Automotive, Delphi Corporation, Autoliv Inc., Takata and Temic. We believe that none of our competitors have a product that is superior to our Bend Sensor^® technology at this time. However, many of our competitors and potential competitors have substantially greater financial, technical and marketing resources, larger customer bases, longer operating histories, greater name recognition and more established relationships than we do. These competitors may be able to undertake more extensive marketing campaigns, adopt more aggressive pricing policies and devote substantially more resources to developing new products and markets than we can.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On November 9, 2017 the Board of Directors authorized the issuance of 4,000,000 shares of restricted common stock to be issued to Empire Fund Managers in consideration for promissory notes with interest totaling $200,000. The shares will be issued in reliance on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

ITEM 6. EXHIBITS

Part I Exhibits


No.	Description
31.1	Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32	Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley

Part II Exhibits


No.	Description
3.1	Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)
3.2	Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)
10.1	Addendum to Lease Agreement between Flexpoint Sensor and Handstands, dated January 1, 2015. (Incorporated by reference to exhibit 10.3 of Form 10-K, filed April 14, 2016)
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who is duly authorized.

FLEXPOINT SENSOR SYSTEMS, INC.

Date: November 14, 2017

/s/ Clark M. Mower

Clark M. Mower

President, Chief Executive Officer and Director,

Principal Financial Officer

EX-31 2 ex311.htm 302 CERTIFICATION OF CLARK M. MOWER, CEO Exhibit 31

Exhibit 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clark M. Mower certify that:

1. I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions);

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 14, 2017

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

EX-31 3 ex312.htm 302 CERTIFICATION OF CLARK M. MOWER, CFO Converted by EDGARwiz

Exhibit 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Clark M. Mower, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc.;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 14, 2017

/s/ Clark M. Mower

Clark M. Mower

Principal Financial Officer

EX-32 4 ex32.htm SECTION 1350 CERTIFICATION Exhibit 32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Flexpoint Sensor Systems, Inc. (the “Company”) for the period ending September 30, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Clark M. Mower, Chief Executive Officer and Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Dated: November 14, 2017

/s/ Clark M. Mower

Clark M. Mower

Chief Executive Officer

Principal Financial Officer

EX-101.INS 5 flxt-20170930.xml XBRL INSTANCE DOCUMENT 0000925660 2017-01-01 2017-09-30 0000925660 2015-12-31 0000925660 us-gaap:MinimumMember 2017-01-01 2017-09-30 0000925660 us-gaap:MaximumMember 2017-01-01 2017-09-30 0000925660 us-gaap:SalesRevenueNetMember flxt:CustomerOneMember 2017-01-01 2017-09-30 0000925660 us-gaap:AccountsReceivableMember flxt:CustomerOneMember 2017-01-01 2017-09-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:DirectorMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:EmployeeMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeOneMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeTwoMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeFourMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember flxt:ExercisePriceRangeThreeMember 2015-08-23 2015-08-24 0000925660 flxt:StockIncentivePlan2005Member 2017-01-01 2017-09-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember 2005-08-25 2016-12-31 0000925660 flxt:StockIncentivePlan2005Member 2017-09-30 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2015-12-31 0000925660 flxt:StockIncentivePlan2005Member us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2015-12-31 0000925660 us-gaap:ChiefExecutiveOfficerMember 2017-09-30 0000925660 us-gaap:ChiefExecutiveOfficerMember 2016-12-31 0000925660 2017-09-30 0000925660 2016-12-31 0000925660 flxt:DerivativeClassificationMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0000925660 flxt:DerivativeClassificationMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0000925660 flxt:DerivativeClassificationMember 2017-01-01 2017-09-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-12-31 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0000925660 us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:TwoThousandSixMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JanuarySixMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:JanuaryThirtyOneMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:MarchSevenMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember flxt:AprilTwentyEightMember 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2016-12-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-07-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-09-30 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-07-02 2016-07-31 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2016-09-01 2016-09-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-09-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-09-30 0000925660 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0000925660 2016-01-01 2016-09-30 0000925660 2016-07-01 2016-09-30 0000925660 2017-07-01 2017-09-30 0000925660 2017-11-14 0000925660 flxt:NewConvertibleNotesPayableMember 2017-09-30 0000925660 flxt:NewConvertibleNotesPayableMember 2017-01-01 2017-09-30 0000925660 flxt:NewConvertibleNotesPayableMember flxt:JuneTwoMember 2017-01-01 2017-09-30 0000925660 flxt:NewConvertibleNotesPayableMember flxt:JulyThirteenMember 2017-01-01 2017-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:DirectorMember 2011-08-08 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:DirectorMember 2011-08-07 2011-08-08 0000925660 2016-09-30 0000925660 us-gaap:ConvertibleNotesPayableMember 2015-12-31 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:MaximumMember 2015-12-31 0000925660 us-gaap:ConvertibleNotesPayableMember us-gaap:MinimumMember 2015-12-31 0000925660 flxt:NonConvertibleNotesPayableMember 2015-12-31 0000925660 us-gaap:ConvertibleNotesPayableMember 2015-01-01 2015-12-31 0000925660 flxt:NonConvertibleNotesPayableMember 2015-01-01 2015-12-31 0000925660 us-gaap:ConvertibleNotesPayableMember 2016-01-01 2016-12-31 0000925660 flxt:NewConvertibleNotesPayableMember flxt:AugustFourteenTwoMember 2017-01-01 2017-09-30 0000925660 flxt:NewConvertibleNotesPayableMember flxt:SeptemberTwentyTwoMember 2017-01-01 2017-09-30 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-09-01 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-08-02 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-08-29 2017-09-01 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-07-29 2017-08-02 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-07-12 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-09-23 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-04-17 0000925660 flxt:ConvertibleNotesPayableRelatedPartyMember us-gaap:OfficerMember 2017-04-16 2017-04-17 0000925660 us-gaap:SubsequentEventMember us-gaap:ConvertibleNotesPayableMember us-gaap:OfficerMember 2017-10-30 0000925660 us-gaap:SubsequentEventMember us-gaap:ConvertibleNotesPayableMember 2017-11-09 0000925660 flxt:OfficerAndDirectorMember 2017-09-30 0000925660 flxt:OfficerAndDirectorMember 2017-01-01 2017-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure FLEXPOINT SENSOR SYSTEMS INC 0000925660 10-Q 2017-09-30 false --12-31 Smaller Reporting Company Q3 2017

1420

102140

588446

586787

915724

876037

99221

0.001

1000000

0.001

100000000

78363464

-0.01

-0.02

-0.01

-0.00

300000

160000

40000

380000

40000

P5Y

P15Y

30903567

24459697

0.18

0.16

-712929

-1329641

-445785

-227958

300000

10000

300000

40000

590000

51000

10000

20000

160000

2016-07-01

2016-09-22

2017-05-25

2016-12-31

2018-07-31

2015-12-31

2016-12-31

2016-11-30

2018-12-31

2017-12-31

2018-12-31

0.10

0.08

2017-12-31

P10Y

2500000

2185000

1960000

225000

640000

500000

50000

995000

3096000

0.14

0.15

0.25

0.20

0.14

2.07

P2Y4M

P3Y

P10Y

2.07

0.14

P10Y

P3Y8M12D

0.0493

0.0160

0.00

4.24

2.00

2.07

0.16

2185000

9144

10823

14916

25295

1000 99221 124340

3153

14916

25295

9792

20000

P8Y7M28D

P7Y10M28D

0.07

0.05

0.07

0.05

0.07

63298

126630

0.00

P0Y2M30D

P1Y2M30D

76295

126630

40892

162520

35403

-112185

126630

63298

0.17

0.16

P7Y10M28D

22049

641865

78363464

1679

1836667

0.17

P3Y

P10Y

-1650

-5711

6550

109358

93847

11383

9348

86914

84499

5080290

5104495

4896917

58321

96358

2860771

2196755

126630

76295

37523

20000

1420173

1184660

1008986

741778

212946

172602

2870563

2196755

5080290

5104495

2209727

2907740

-26935740

-26222811

29067104

29052188

78363

256323

232569

104364

40622

-586612

-614610

-181521

-217779

842935

847179

285885

258401

244484

241055

81715

79975

515620

525245

171888

160769

43144

16369

13859

8503

39687

64510

18423

9154

-126317

-715031

-264264

-10179

112185

63006

5746

1916

238537

720777

266180

73197

78363464

71656107

71712536

78363464

-312668

-414600

336342

273121

-1420

2159

40344

29253

2034

-2613

2415

124775

22706

11061

2395

11061

-20311

325379

400000

47000

-14621

5711

10958

8950 9300 9600

0.8133

1.1834

0.0106

0.0131

0.15 0.15

0.07

0.025

51157

684660

123797

40000

123797

2700000

684660

7000

4000000

1650

<div style="width: 624px"> NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Condensed Consolidated Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the Company). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Companys Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Companys significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017. Nature of Operations Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Companys activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Companys operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through September 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. Fair Value Measurements - The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the partys own credit risk.   Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:   Level 1: Quoted market prices in active markets for identical assets or liabilities.   Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.   Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.   To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.   The carrying value of the Companys cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.   The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company. Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and production generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $102,140 and $102,140 in the periods ended September 30, 2017 and December 31, 2016, respectively.   Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years. Valuation of Long-lived Assets The carrying values of the Companys long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required. Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.   Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. Goodwill Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or ASC) 350-20 Intangibles Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Companys assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value. Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.  The Company does not provide extended warranties or guarantees on its products. Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.   All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended September 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $14,916 and $25,295, respectively. Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2017 and September 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 30,903,567 and 24,459,697, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share. Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the nine-month period ended September 30, 2017, a customer who manufacturers gloves containing our sensors represented 18% of sales and represented 16% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Companys technologies.   Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized. Recent Accounting Pronouncements In August 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-12, Derivatives and Hedging (Topic 815).  The new standard amends the hedge accounting recognition and presentation requirements in ASC 815.  This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  Early adoption is permitted.  The Company is currently evaluating the timing of adopting the new guidance as well as the impact it may have on its consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </div>

<div style="width: 624px">NOTE 2 GOING CONCERN The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,935,740 at September 30, 2017.  These factors raise substantial doubt about the Companys ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of these uncertainties.  The Company has relied on raising additional capital through the issuance of convertible notes payable; however, there is no assurance that additional funding will be available on acceptable terms, if at all.</div>

<div style="width: 624px">NOTE 3 DERIVATIVE INSTRUMENTS The derivative liability as of September 30, 2017, in the amount of $126,630 has a Level 3 fair value classification. The following table provides a summary of changes in fair value of the Companys Level 3 financial liabilities as of September 30, 2017 and December 31, 2016:   <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 139px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, December 31, 2015</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Recognition of derivative liabilities upon initial valuation</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> 40,892</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Change in fair value of derivative liabilities</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 35,403</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Conversions of derivative liabilities into equity instruments</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, December 31, 2016</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 76,295</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Recognition of derivative liabilities upon initial valuation</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> 162,520 </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Change in fair value of derivative liabilities</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> (112,185) </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Conversions of derivative liabilities into equity instruments</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, September 30, 2017</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> </table>   During the year ended 2016 and the period ended September 30, 2017, the Company issued convertible promissory notes which are convertible into common stock. Due to the Companys lack of authorized shares necessary to settle all convertible instruments, in accordance with ASC 815-40-25, the Company determined that the conversion features related to these notes are derivative instruments since we do not have control to increase the number of authorized shares to settle all convertible instruments.  The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of debenture and to fair value as of each subsequent reporting date.   At September 30, 2017, the Company marked to market the fair value of the derivatives and determined a fair value of $126,630. The Company recorded a gain from change in fair value of derivatives of $112,185 for the nine month period ended September 30, 2017. During the nine months ended September 30, 2017, the Company recorded additional interest expense of $63,298 and debt discounts of $99,221 in connection with the recognition of derivative liabilities. The fair value of the embedded derivatives was determined using binomial lattice model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 81.33% to 118.34%, (3) weighted average risk-free interest rate of 1.06% to 1.31% (4) expected life of 0.25 to 1.25 years, and (5) the quoted market price of the Companys common stock at each valuation date.   In accordance ASC 840-15-25, the Company has implemented a sequencing policy with respect to all outstanding convertible instruments. The Company evaluates its contracts based upon earliest issuance date.    As of September 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows: <table cellpadding="0" cellspacing="0" align="center" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 69px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 1</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 2</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 3</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td></tr> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Derivative Liabilities</td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td></tr> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 126,630</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 126,630</td></tr> </table> Convertible Notes Payable During 2015 the Company secured additional financing to cover its ongoing operations in the amount of $590,000 by issuing various convertible notes bearing 10% annual interest (15% default interest), secured by business assets and carrying exercise prices ranging between $0.025 and $0.07 per share. Additionally, during 2015 the Company issued $51,000 for a non-convertible note payable bearing 10% annual interest (15% default interest) and secured by the $51,157 note receivable held by the Company (see Note 2). During 2015, all of these notes (both convertible and non-convertible issued in 2014 and 2015) and accrued interest were either converted into common stock or extinguished and consolidated into two remaining convertible notes payable to two investors in principal amounts of $684,660 and $123,797 (with respective maturity dates of December 31, 2016 and November 30, 2016). Both notes are convertible at $0.05 per share, bear 10% annual interest rates (15% default interest) and are secured by business assets. During 2016 the Company approved the conversion of the convertible note payable in the amount of $123,797 into 2.7 million shares of common stock. As of September 30, 2017, the principle balance of the convertible note payable in the amount of $684,660 remains outstanding. The Company entered into a new promissory note for up to $300,000 from a third party on May 25, 2017.  The note has an annual interest rate of 10% and is secured by the Companys equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of July 31, 2018.  The Company drew $40,000 against that note on June 2, 2017, $40,000 on July 13, 2017, $40,000 on August 14, 2017 and $40,000 on September 22, 2017.    </div> The Company entered into a convertible promissory note for up to $300,000 from a third party on July 1, 2016.  The note has an annual interest rate of 10% and is secured by the Companys equipment.  The note has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  The Company drew $160,000 against that note during 2016 and $40,000 on January 6, 2017; $40,000 on January 31, 2017 $40,000 on March 7, 2017 and the balance of $20,000 on April 28, 2017. On August 8, 2011, the Company entered into a convertible note payable with a former Company Director for $40,000. This note was due on December 31, 2015, bears an annual interest rate of 10% annual interest and is secured by business equipment. Convertible Note Payable Related Party On September 1, 2017 the Company issued a note for $10,000 to an officer of the Company.  The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2018.  The note is secured by all of the Companys business equipment. On August 2, 2017 the Company issued a note for $10,000 to an officer of the Company.  The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2017.  The note is secured by all of the Companys business equipment. On July 12, 2017, an officer of the Company provided $7,000 to the Company under a line of credit.  On September 23, 2017 the Company paid $7,000 to fully retire that obligation. On April 17, 2017 the Company issued a note for $20,000 to an officer of the Company.  The note bears interest at the rate of 8%, has a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2018.  The note is secured by all of the Companys business equipment. On July 1, 2016 and September 22, 2016, the Company issued two promissory notes for $10,000 each to an officer of the Company.  The notes bear interest at the rate of 10%, have a conversion feature for restricted common shares at $0.07 per share and a maturity date of December 31, 2016.  Since the fair value of the common stock at the date of the July 1, 2016 advance was $0.07, no BCF was recorded.

NOTE 4 STOCK OPTION PLANS On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and will continue in effect for ten years, unless terminated.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Companys trading common stock for the thirty day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares.  The Company continues to utilize the Black-Scholes option-pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock. On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Companys common stock.  Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees.  Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share.  Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two year four month period in equal installments on the last day of 2015, 2016 and 2017, respectively.  We relied on an exemption from the registration requirements provided by Section 4(a)(2) of the Securities Act. Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.  Between August 25, 2005 and December 31, 2015, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.14 to $2.07 per share.  The options vest over three years and expire 10 years from the date of grant.  The Company used the following assumptions in estimating the fair value of the options granted: · Market value at the time of issuance Range of $0.14 to 2.07 · Expected term Range of 3.7 years to 10.0 years · Risk-free interest rate Range of 1.60% to 4.93% · Dividend yield 0% · Expected volatility 200% to 424% · Weighted-average fair value - $0.16 to $2.07 During the nine months ended September 30, 2017, the Company recognized a total of $14,916 of stock-based compensation expense, leaving $3,153 in unrecognized expense as of September 30, 2017. During the nine months ended September 30, 2016, the Company recognized $25,295 in stock-based compensation expense. There were 2,185,000 and 2,185,000 employee stock options outstanding at September 30, 2017 and December 31, 2016, respectively.   A summary of all employee options outstanding and exercisable under the plan as of September 30, 2017, and changes during the three months then ended is set forth below: <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 237px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Options</td> <td style="width: 90px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Shares</td> <td style="width: 114px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Weighted Average Exercise Price</td> <td style="width: 83px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Weighted Average Remaining Contractual  Life (Years)</td> <td style="width: 85px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Aggregate Intrinsic Value</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Outstanding at the beginning of period </td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">          2,185,000</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                0.16</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              8.66 </td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $              --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Granted</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                    --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                  --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Expired</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                      --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                              --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                   --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                  --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Forfeited</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                    --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                 --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Outstanding at the end of Period</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">        2,185,000</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                 0.17</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              7.91</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $               --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Exercisable at the end of Period</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 1,836,667</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                 0.17</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              7.91</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $               --</td></tr></table>

<div style="width: 624px">NOTE 5 CAPITAL STOCK Preferred Stock There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized.  At September 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding. Common Stock There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized.  No shares of stock were issued during the nine months ended September 30, 2017.  </div>

<div style="width: 624px">NOTE 6 - COMMITMENTS AND CONTINGENCIES The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017.  Either party may terminate the lease upon 90 day written notice.  Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017.</div>

<div style="width: 624px">NOTE 7 RELATED PARTY TRANSACTIONS At September 30, 2017 and December 31, 2016, the Company had accounts payable of $-0- and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business.   During the period an Officer of the Company and Director of the Company assumed a total of $54,513 in accrued liabilities owed by the Company. The Company recorded the amount assumed as a due to related party on the balance sheet in the amount of $54,513 as of September 30, 2017. The amounts due to both the Officer and Director accrue interest at 8%, have a conversion feature for restricted common shares at $0.07 per share and must be repaid by December 31, 2018. </div>

<div style="width: 624px">NOTE 8 - SUBSEQUENT EVENTS On November 1, 2017 the Company received a short-term loan in the amount of $20,000 from an officer of the Company.  The Company intends to repay the loan when funds are available.  No terms have been established for this loan at the date of this filing.   On November 9, 2017 the Company authorized the conversion of promissory notes totaling $160,000 and accrued interest in the amount of $40,000 through the issuance of 4,000,000 shares of its restricted common stock.  The conversion rate was $0.05 per share, pursuant to the terms of the convertible note agreements. The stock has not been issued as of the date of this filing.  </div>

<div style="width: 624px"> Condensed Consolidated Interim Financial Statements The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the Company). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Companys Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Companys significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017. </div>

<div style="width: 624px"> Nature of Operations Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Companys activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Companys operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through September 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work. </div>

<div style="width: 624px"> Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates. </div>

<div style="width: 624px"> Cash and Cash Equivalents Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. </div>

<div style="width: 624px">Fair Value Measurements - The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the partys own credit risk.   Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:   Level 1: Quoted market prices in active markets for identical assets or liabilities.   Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.   Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.   To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.   The carrying value of the Companys cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.   The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.</div>

<div style="width: 624px"> Accounts Receivable Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and production generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances.  The balance in the allowance account was $102,140 and $102,140 in the periods ended September 30, 2017 and December 31, 2016, respectively.   </div>

<div style="width: 624px"> Property and Equipment Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years. </div>

<div style="width: 624px"> Valuation of Long-lived Assets The carrying values of the Companys long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required. </div>

<div style="width: 624px"> Intangible Assets Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. </div>

<div style="width: 624px"> Research and Development Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. </div>

<div style="width: 624px"> Goodwill Goodwill represents the excess of the Companys reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or ASC) 350-20 Intangibles Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Companys assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value. </div>

<div style="width: 624px"> Revenue Recognition Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers.  Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer.  Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts.  The Company does not provide extended warranties or guarantees on its products. </div>

<div style="width: 624px"> Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest.   All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended September 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $14,916 and $25,295, respectively. </div>

<div style="width: 624px"> Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2017 and September 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 30,903,567 and 24,459,697, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share. </div>

<a name="_GoBack"><div style="width: 624px">Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable.  During the nine-month period ended September 30, 2017, a customer who manufacturers gloves containing our sensors represented 18% of sales and represented 16% of accounts receivable.  The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Companys technologies.  </div></a>

<div style="width: 624px"> Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized. </div>

<div style="width: 624px">Recent Accounting Pronouncements In August 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-12, Derivatives and Hedging (Topic 815).  The new standard amends the hedge accounting recognition and presentation requirements in ASC 815.  This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years.  Early adoption is permitted.  The Company is currently evaluating the timing of adopting the new guidance as well as the impact it may have on its consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows.  Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations. </div>

The following table provides a summary of changes in fair value of the Companys Level 3 financial liabilities as of September 30, 2017 and December 31, 2016:   <div style="width: 662px"> 8 <hr size="1" noshade="noshade" style="margin-bottom: 9px; padding-top: 9px" /> </div> <div style="width: 624px">   <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 139px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, December 31, 2015</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Recognition of derivative liabilities upon initial valuation</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> 40,892</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Change in fair value of derivative liabilities</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 35,403</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Conversions of derivative liabilities into equity instruments</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, December 31, 2016</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 76,295</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Recognition of derivative liabilities upon initial valuation</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> 162,520 </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Change in fair value of derivative liabilities</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> (112,185) </td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> Conversions of derivative liabilities into equity instruments</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 2px solid; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom"> -</td> <td style="width: 1px; padding: 0px 9px; margin-top: 0px; background-color: #ffffff; vertical-align: bottom">  </td></tr> <tr> <td style="width: 336px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Balance, September 30, 2017</td> <td style="width: 36px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 29px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 17px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 1px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 137px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td> </tr></table></div>

As of September 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows: <table cellpadding="0" cellspacing="0" align="center" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 69px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 1</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 2</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Level 3</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td colspan="2" style="width: 68px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td></tr> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> Derivative Liabilities</td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom">  </td> <td style="width: 62px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; background-color: #cceeff; vertical-align: bottom"> 126,630</td></tr> <tr> <td style="width: 275px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Total</td> <td style="width: 13px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> -</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 126,630</td> <td style="width: 6px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 12px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 6px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $</td> <td style="width: 62px; border-bottom: #000000 3px double; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 126,630</td></tr> </table>

<div style="width: 624px"> A summary of all employee options outstanding and exercisable under the plan as of September 30, 2017, and changes during the three months then ended is set forth below: <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0px"> <tr> <td style="width: 237px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Options</td> <td style="width: 90px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Shares</td> <td style="width: 114px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Weighted Average Exercise Price</td> <td style="width: 83px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Weighted Average Remaining Contractual  Life (Years)</td> <td style="width: 85px; border-bottom: #000000 1px solid; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Aggregate Intrinsic Value</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  </td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Outstanding at the beginning of period </td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">          2,185,000</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                0.16</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              8.66 </td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $              --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Granted</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                    --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                  --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Expired</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                      --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                              --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                   --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                  --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">    Forfeited</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> --</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                    --</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">                 --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Outstanding at the end of Period</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">        2,185,000</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                 0.17</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              7.91</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $               --</td></tr> <tr> <td style="width: 237px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> Exercisable at the end of Period</td> <td style="width: 90px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> 1,836,667</td> <td style="width: 114px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">  $                 0.17</td> <td style="width: 83px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom">              7.91</td> <td style="width: 85px; padding: 0px 9px; margin-top: 0px; vertical-align: bottom"> $               --</td></tr></table></div>

-7000

20000

54513

EX-101.SCH 6 flxt-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - DERIVATIVE INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - STOCK OPTION PLANS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCK OPTION PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - GOING CONCERN (Details) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - CAPITAL STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 flxt-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 flxt-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 flxt-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Range [Axis] Minimum [Member] Maximum [Member] Concentration Risk Benchmark [Axis] Sales [Member] Customer [Axis] Customer One [Member] Accounts Receivable [Member] Plan Name [Axis] 2005 Stock Incentive Plan [Member] Award Type [Axis] Stock Options [Member] Related Party [Axis] Director [Member] Title of Individual [Axis] Employee [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Four [Member] Exercise Price Range Three [Member] Chief Executive Officer [Member] Debt Instrument [Axis] Derivative Classification [Member] Liability Class [Axis] Derivative Financial Instruments, Liabilities [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Fair Value, Hierarchy [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Convertible Notes Payable [Member] Debt Instrument [Axis] 2016 [Member] January 6 [Member] January 31 [Member] March 7 [Member] April 28 [Member] Convertible Notes Payable to Related Party [Member] Officer [Member] New Convertible Notes Payable [Member] June 2 [Member] July 13 [Member] Non Convertible Notes Payable [Member] August 14 [Member] September 22 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Officer and Director [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Accounts receivable, net of allowance for bad debts of $102,140 and $102,140 Deposits, prepaid expenses, and other current assets Total Current Assets Long-Term Deposits Property and Equipment, net of accumulated depreciation of $588,446 and $586,787 Patents and Proprietary Technology, net of accumulated amortization of $915,724 and $876,037 Goodwill Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable Accounts payable - related party Accrued liabilities Due to related parties Convertible notes payable, net Convertible notes payable to related party, net Derivative liabilities Total current liabilities Long-term Liabilities Convertible notes payable to related party, net Total Liabilities Stockholders' Equity Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding Common stock - $0.001 par value; 100,000,000 shares authorized; 78,363,464 shares and 78,363,464 shares issued and 78,363 outstanding Additional paid-in capital Accumulated deficit Total Stockholders' Equity Total Liabilities and Stockholders' Equity Accounts receivable, allowance for bad debts Property and Equipment, accumulated depreciation Patents and Proprietary Technology, accumulated amortization Preferred stock, par value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Design, Contract and Testing Revenue Operating Costs and Expenses Amortization of patents and proprietary proprietary technology Cost of revenue Administrative and marketing expense Research and development expense Total Operating Costs and Expenses Net Operating Loss Other Income and Expenses Interest expense Interest income Gain on derivative Net Other Income (Expense) Net Loss Basic and Diluted Loss per Common Share Basic and Diluted Weighted-Average Common Shares Outstanding Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Stock subscription for compensation Stock-based compensation expense Amortization of patents and proprietary technology Amortization of discount on note payable Depreciation Change in fair value of derivative liabilities Interest expense recognized for derivative liabilities Changes in operating assets and liabilities: Accounts receivable Deposits and prepaid expenses Accounts payable Accounts payable - related parties Accrued liabilities Net Cash Used in Operating Activities Cash Flows from Investing Activities: Purchase of proprietary technology Note receivable interest income Net Cash Used in Investing Activities Cash Flows from Financing Activities: Repayment of bank overdrafts Proceeds from borrowings under convertible note payable - related party Repayment of borrowings under convertible note payable - related party Proceeds from borrowings under convertible note payable Net Cash Provided by Financing Activities Net Change in Cash and Cash Equivalents Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period Supplemental Cash Flow Information: Cash paid for income taxes Cash paid for interest Supplemental Disclosure on Noncash Investing and Financing Activities Recognition of discounts on convertible notes payable Stock issued for subscription payable Assumption of liabilities by related parties SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN[Abstract] GOING CONCERN DERIVATIVE INSTRUMENTS [Abstract] DERIVATIVE INSTRUMENTS STOCK OPTION PLANS [Abstract] STOCK OPTION PLANS CAPITAL STOCK [Abstract] CAPITAL STOCK COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES RELATED PARTY TRANSACTIONS [Abstract] RELATED PARTY TRANSACTIONS SUBSEQUENT EVENTS [Abstract] SUBSEQUENT EVENTS Condensed Consolidated Interim Financial Statements Nature of Operations Use of Estimates Cash and Cash Equivalents. Fair Value Measurements Accounts Receivable Inventories Business Condition Property and Equipment. Valuation of Long-lived Assets Intangible Assets Research and Development Goodwill Revenue Recognition EX-101.PRE 10 flxt-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Nov. 14, 2017
Document And Entity Information
Entity Registrant Name	FLEXPOINT SENSOR SYSTEMS INC
Entity Central Index Key	0000925660
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		78,363,464
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2017

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents	$ 11,061
Accounts receivable, net of allowance for bad debts of $102,140 and $102,140	86,914	84,499
Deposits, prepaid expenses, and other current assets	11,383	9,348
Total Current Assets	109,358	93,847
Long-Term Deposits	6,550	6,550
Property and Equipment, net of accumulated depreciation of $588,446 and $586,787	9,144	10,823
Patents and Proprietary Technology, net of accumulated amortization of $915,724 and $876,037	58,321	96,358
Goodwill	4,896,917	4,896,917
Total Assets	5,080,290	5,104,495
Current Liabilities
Accounts payable	212,946	172,602
Accounts payable - related party		1,420
Accrued liabilities	1,008,986	741,778
Due to related parties	54,513
Convertible notes payable, net	1,420,173	1,184,660
Convertible notes payable to related party, net	37,523	20,000
Derivative liabilities	126,630	76,295
Total current liabilities	2,860,771	2,196,755
Long-term Liabilities
Convertible notes payable to related party, net	9,792
Total Liabilities	2,870,563	2,196,755
Stockholders' Equity
Preferred stock - $0.001 par value; 1,000,000 shares authorized; no shares issued or outstanding
Common stock - $0.001 par value; 100,000,000 shares authorized; 78,363,464 shares and 78,363,464 shares issued and 78,363 outstanding	78,363	78,363
Additional paid-in capital	29,067,104	29,052,188
Accumulated deficit	(26,935,740)	(26,222,811)
Total Stockholders' Equity	2,209,727	2,907,740
Total Liabilities and Stockholders' Equity	$ 5,080,290	$ 5,104,495

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Accounts receivable, allowance for bad debts	$ 102,140	$ 102,140
Property and Equipment, accumulated depreciation	588,446	586,787
Patents and Proprietary Technology, accumulated amortization	$ 915,724	$ 876,037
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	78,363,464	78,363,464
Common stock, shares outstanding	78,363,464	78,363,464

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Design, Contract and Testing Revenue	$ 40,622	$ 104,364	$ 256,323	$ 232,569
Operating Costs and Expenses
Amortization of patents and proprietary proprietary technology	9,154	18,423	39,687	64,510
Cost of revenue	8,503	13,859	43,144	16,369
Administrative and marketing expense	160,769	171,888	515,620	525,245
Research and development expense	79,975	81,715	244,484	241,055
Total Operating Costs and Expenses	258,401	285,885	842,935	847,179
Net Operating Loss	(217,779)	(181,521)	(586,612)	(614,610)
Other Income and Expenses
Interest expense	(73,197)	(266,180)	(238,537)	(720,777)
Interest income	12	1,916	35	5,746
Gain on derivative	63,006		112,185
Net Other Income (Expense)	(10,179)	(264,264)	(126,317)	(715,031)
Net Loss	$ (227,958)	$ (445,785)	$ (712,929)	$ (1,329,641)
Basic and Diluted Loss per Common Share	$ (0.00)	$ (0.01)	$ (0.01)	$ (0.02)
Basic and Diluted Weighted-Average Common Shares Outstanding	78,363,464	71,712,536	78,363,464	71,656,107

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash Flows from Operating Activities:
Net loss	$ (712,929)	$ (1,329,641)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock subscription for compensation		1,000
Stock-based compensation expense	14,916	25,295
Amortization of patents and proprietary technology	39,687	64,510
Amortization of discount on note payable	22,049	641,865
Depreciation	1,679
Change in fair value of derivative liabilities	(112,185)
Interest expense recognized for derivative liabilities	63,298
Changes in operating assets and liabilities:
Accounts receivable	(2,415)	(124,775)
Deposits and prepaid expenses	(2,034)	2,613
Accounts payable	40,344	29,253
Accounts payable - related parties	(1,420)	2,159
Accrued liabilities	336,342	273,121
Net Cash Used in Operating Activities	(312,668)	(414,600)
Cash Flows from Investing Activities:
Purchase of proprietary technology	(1,650)
Note receivable interest income		(5,711)
Net Cash Used in Investing Activities	(1,650)	(5,711)
Cash Flows from Financing Activities:
Repayment of bank overdrafts	(14,621)
Proceeds from borrowings under convertible note payable - related party	47,000
Repayment of borrowings under convertible note payable - related party	(7,000)	20,000
Proceeds from borrowings under convertible note payable	300,000	380,000
Net Cash Provided by Financing Activities	325,379	400,000
Net Change in Cash and Cash Equivalents	11,061	(20,311)
Cash and Cash Equivalents at Beginning of Period		22,706
Cash and Cash Equivalents at End of Period	11,061	2,395
Supplemental Cash Flow Information:
Cash paid for income taxes
Cash paid for interest
Supplemental Disclosure on Noncash Investing and Financing Activities
Recognition of discounts on convertible notes payable	99,221	124,340
Stock issued for subscription payable		10,958
Assumption of liabilities by related parties	$ 54,513

XML 16 R6.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1– SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES *Condensed Consolidated Interim Financial Statements –* The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017. *Nature of Operations* – Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through September 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work. *Use of Estimates –* The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. *Cash and Cash Equivalents –* Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less. Fair Value Measurements - The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The carrying value of the Company’s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company. *Accounts Receivable –* Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and production generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. The balance in the allowance account was $102,140 and $102,140 in the periods ended September 30, 2017 and December 31, 2016, respectively. Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years. *Valuation of Long-lived Assets* – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required. *Intangible Assets* – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. *Research and Development* – Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable. *Goodwill* – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value. *Revenue Recognition –* Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. The Company does not provide extended warranties or guarantees on its products. *Stock-Based Compensation* – The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended September 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $14,916 and $25,295, respectively. *Basic and Diluted Loss Per Share –* Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2017 and September 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 30,903,567 and 24,459,697, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share. *Concentrations and Credit Risk -* The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. During the nine-month period ended September 30, 2017, a customer who manufacturers gloves containing our sensors represented 18% of sales and represented 16% of accounts receivable. The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies. *Income Taxes -* The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized. *Recent Accounting Pronouncements* – In August 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815).” The new standard amends the hedge accounting recognition and presentation requirements in ASC 815. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adopting the new guidance as well as the impact it may have on its consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 17 R7.htm IDEA: XBRL DOCUMENT

GOING CONCERN	9 Months Ended
GOING CONCERN	Sep. 30, 2017
GOING CONCERN[Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The Company continues to accumulate significant operating losses and has an accumulated deficit of $26,935,740 at September 30, 2017. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. The Company has relied on raising additional capital through the issuance of convertible notes payable; however, there is no assurance that additional funding will be available on acceptable terms, if at all.

XML 18 R8.htm IDEA: XBRL DOCUMENT

DERIVATIVE INSTRUMENTS

9 Months Ended

Sep. 30, 2017

DERIVATIVE INSTRUMENTS [Abstract]

DERIVATIVE INSTRUMENTS

NOTE 3 – DERIVATIVE INSTRUMENTS

The derivative liability as of September 30, 2017, in the amount of $126,630 has a Level 3 fair value classification.

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2017 and December 31, 2016:

	Total
Balance, December 31, 2015		-
Recognition of derivative liabilities upon initial valuation		40,892
Change in fair value of derivative liabilities		35,403
Conversions of derivative liabilities into equity instruments		-
Balance, December 31, 2016		76,295
Recognition of derivative liabilities upon initial valuation		162,520
Change in fair value of derivative liabilities		(112,185)
Conversions of derivative liabilities into equity instruments		-
Balance, September 30, 2017		126,630

As of September 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:

	Level 1		Level 2		Level 3		Total
Derivative Liabilities		-		-		126,630		126,630
Total	$	-	$	-	$	126,630	$	126,630

Convertible Notes Payable

Convertible Note Payable Related Party

On July 12, 2017, an officer of the Company provided $7,000 to the Company under a line of credit. On September 23, 2017 the Company paid $7,000 to fully retire that obligation.

XML 19 R9.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS

9 Months Ended

Sep. 30, 2017

STOCK OPTION PLANS [Abstract]

STOCK OPTION PLANS

NOTE 4 – STOCK OPTION PLANS

Market value at the time of issuance – Range of $0.14 to 2.07

Expected term – Range of 3.7 years to 10.0 years

Risk-free interest rate – Range of 1.60% to 4.93%

Dividend yield – 0%

Expected volatility – 200% to 424%

Weighted-average fair value - $0.16 to $2.07

A summary of all employee options outstanding and exercisable under the plan as of September 30, 2017, and changes during the three months then ended is set forth below:

Options	Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$ 0.16	8.66	$ --
Granted	--	--	--	--
Expired	--	--	--	--
Forfeited	--	--	--	--
Outstanding at the end of Period	2,185,000	$ 0.17	7.91	$ --
Exercisable at the end of Period	1,836,667	$ 0.17	7.91	$ --

XML 20 R10.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK	9 Months Ended
CAPITAL STOCK	Sep. 30, 2017
CAPITAL STOCK [Abstract]
CAPITAL STOCK	NOTE 5 – CAPITAL STOCK Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At September 30, 2017 and December 31, 2016, there were no shares of preferred stock issued or outstanding. Common Stock – There are 100,000,000 shares of common stock with a par value of $0.001 per share authorized. No shares of stock were issued during the nine months ended September 30, 2017.

XML 21 R11.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2017
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 - COMMITMENTS AND CONTINGENCIES The Company currently occupies a manufacturing facility in Draper, Utah. The lease on the facility expired on December 31, 2014, at which time the Company entered into a three year extension which will expire on December 31, 2017. Either party may terminate the lease upon 90 day written notice. Under the terms of the lease the Company paid $8,950 per month in 2015 (the same rate as in 2014), $9,300 per month in 2016 and $9,600 per month in 2017.

XML 22 R12.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2017
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS At September 30, 2017 and December 31, 2016, the Company had accounts payable of $-0- and $1,420 to its Chief Executive Office for reimbursement of various operating expenses paid by him in the course of business. During the period an Officer of the Company and Director of the Company assumed a total of $54,513 in accrued liabilities owed by the Company. The Company recorded the amount assumed as a due to related party on the balance sheet in the amount of $54,513 as of September 30, 2017. The amounts due to both the Officer and Director accrue interest at 8%, have a conversion feature for restricted common shares at $0.07 per share and must be repaid by December 31, 2018.

XML 23 R13.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2017
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 8 - SUBSEQUENT EVENTS On November 1, 2017 the Company received a short-term loan in the amount of $20,000 from an officer of the Company. The Company intends to repay the loan when funds are available. No terms have been established for this loan at the date of this filing. On November 9, 2017 the Company authorized the conversion of promissory notes totaling $160,000 and accrued interest in the amount of $40,000 through the issuance of 4,000,000 shares of its restricted common stock. The conversion rate was $0.05 per share, pursuant to the terms of the convertible note agreements. The stock has not been issued as of the date of this filing.

XML 24 R14.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2017
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Condensed Consolidated Interim Financial Statements	*Condensed Consolidated Interim Financial Statements –* The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its subsidiaries (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. and subsidiaries for the year ended December 31, 2016 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on April 18, 2017. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2017.
Nature of Operations	*Nature of Operations* – Flexpoint Sensor Systems, Inc. (the Company) is located in Draper, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through September 30, 2017 the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.
Use of Estimates	*Use of Estimates –* The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Cash and Cash Equivalents.	*Cash and Cash Equivalents –* Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.
Fair Value Measurements	Fair Value Measurements - The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The carrying value of the Company’s cash, accounts payable, short-term borrowings, (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. The Company has classified the inputs used in valuing its derivative liabilities as Level 3 inputs. The Company valued its derivatives using the binomial lattice model. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed below are that of volatility and market price of the underlying common stock of the Company.
Accounts Receivable	*Accounts Receivable –* Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and production generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project is completed and accepted by the customer, at which time the entire contract price is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. The balance in the allowance account was $102,140 and $102,140 in the periods ended September 30, 2017 and December 31, 2016, respectively.
Property and Equipment.	Property and Equipment – Property and equipment are stated at cost. Additions and major improvements are capitalized while maintenance and repairs are charged to operations. Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.
Valuation of Long-lived Assets	*Valuation of Long-lived Assets* – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.
Intangible Assets	*Intangible Assets* – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology. Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years. An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows.
Research and Development	*Research and Development* – Research and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.
Goodwill	*Goodwill* – Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.
Revenue Recognition	*Revenue Recognition –* Revenue is recognized when persuasive evidence of an arrangement exists, services have been provided or goods delivered, the price to the buyer is fixed or determinable and collectability is reasonably assured. Revenue from the sale of products is recorded at the time of shipment to the customers. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contracts are met and then recognized as licensing royalty revenue over the remaining term of the contracts. The Company does not provide extended warranties or guarantees on its products.
Stock-Based Compensation	*Stock-Based Compensation* – The Company recognizes the cost of employee services received in exchange for stock options and awards of equity instruments based on the grant-date fair value of such options and awards, over the period they vest. All share-based compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense in operations over the requisite service period. For the periods ended September 30, 2017 and 2016, the Company recognized expense for stock-based compensation of $14,916 and $25,295, respectively.
Basic and Diluted Loss Per Share	*Basic and Diluted Loss Per Share –* Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At September 30, 2017 and September 30, 2016, there were outstanding common share equivalents (options and convertible notes payable) which amounted to 30,903,567 and 24,459,697, respectively, of common stock. These common share equivalents were not included in the computation of diluted loss per share as their effect would have been anti-dilutive, thereby decreasing loss per common share.
Concentrations and Credit Risk	*Concentrations and Credit Risk -* The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. During the nine-month period ended September 30, 2017, a customer who manufacturers gloves containing our sensors represented 18% of sales and represented 16% of accounts receivable. The Company has a strong ongoing relationship with this customer with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.
Income Taxes	*Income Taxes -* The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized.
Recent Accounting Pronouncements	*Recent Accounting Pronouncements* – In August 2017, the Financial Accounting Standards Board ("FASB") issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815).” The new standard amends the hedge accounting recognition and presentation requirements in ASC 815. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the timing of adopting the new guidance as well as the impact it may have on its consolidated financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

XML 25 R15.htm IDEA: XBRL DOCUMENT

DERIVATIVE INSTRUMENTS (Tables)

9 Months Ended

Sep. 30, 2017

Derivative Instruments Tables

Schedule of Changes in Level 3 Financial Liabilities

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities as of September 30, 2017 and December 31, 2016:

	Total
Balance, December 31, 2015		-
Recognition of derivative liabilities upon initial valuation		40,892
Change in fair value of derivative liabilities		35,403
Conversions of derivative liabilities into equity instruments		-
Balance, December 31, 2016		76,295
Recognition of derivative liabilities upon initial valuation		162,520
Change in fair value of derivative liabilities		(112,185)
Conversions of derivative liabilities into equity instruments		-
Balance, September 30, 2017		126,630

Schedule of Liabilities Measured at Fair Value on Recurring Basis

As of September 30, 2017, liabilities measured at fair value on a recurring basis are summarized as follows:

	Level 1		Level 2		Level 3		Total
Derivative Liabilities		-		-		126,630		126,630
Total	$	-	$	-	$	126,630	$	126,630

XML 26 R16.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Tables)

9 Months Ended

Sep. 30, 2017

STOCK OPTION PLANS [Abstract]

Schedule of Stock Option Activity

A summary of all employee options outstanding and exercisable under the plan as of September 30, 2017, and changes during the three months then ended is set forth below:

Options	Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value

Outstanding at the beginning of period	2,185,000	$ 0.16	8.66	$ --
Granted	--	--	--	--
Expired	--	--	--	--
Forfeited	--	--	--	--
Outstanding at the end of Period	2,185,000	$ 0.17	7.91	$ --
Exercisable at the end of Period	1,836,667	$ 0.17	7.91	$ --

XML 27 R17.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Nature Of Business [Line Items]
Accounts receivable, allowance for bad debts	$ 102,140		$ 102,140
Stock-based compensation expense	$ 14,916	$ 25,295
Anti-dilutive securities excluded from computation of earnings per share amount	30,903,567	24,459,697
Sales [Member] \| Customer One [Member]
Nature Of Business [Line Items]
Risk percentage	18.00%
Accounts Receivable [Member] \| Customer One [Member]
Nature Of Business [Line Items]
Risk percentage	16.00%
Minimum [Member]
Nature Of Business [Line Items]
Property and equipment, useful lives	P3Y
Intangible assets, useful lives	5 years
Maximum [Member]
Nature Of Business [Line Items]
Property and equipment, useful lives	P10Y
Intangible assets, useful lives	15 years

XML 28 R18.htm IDEA: XBRL DOCUMENT

GOING CONCERN (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Going Concern Details
Accumulated deficit	$ (26,935,740)	$ (26,222,811)

XML 29 R19.htm IDEA: XBRL DOCUMENT

DERIVATIVE INSTRUMENTS (Narrative) (Details) - USD ($)					1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
DERIVATIVE INSTRUMENTS (Narrative) (Details) - USD ($)	Sep. 01, 2017	Aug. 02, 2017	Apr. 17, 2017	Aug. 08, 2011	Sep. 30, 2016	Jul. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Sep. 23, 2017	Jul. 12, 2017
Derivative liabilities							$ 126,630		$ 126,630
Loss on change in fair value of derivative liabilities							63,006		112,185
Interest expense in connection with recognition of derivative liabilities									63,298
Proceeds from borrowings under convertible note payable									300,000	380,000
Convertible notes payable, balance							9,792		9,792
Discount balance							99,221		99,221
Convertible Notes Payable [Member]
Debt instrument, face amount							$ 300,000		$ 300,000			$ 590,000
Debt instrument, issuance date									Jul. 01, 2016
Debt instrument, maturity date									Dec. 31, 2016			Dec. 31, 2016
Debt instrument, interest rate							10.00%		10.00%		10.00%	10.00%
Debt instrument, default rate												15.00%
Convertible notes payable, principal amount outstanding							$ 684,660		$ 684,660
Accrued interest												$ 684,660
Fair value of common stock advance											$ 123,797
Debt instrument, conversion price							$ 0.07		$ 0.07			$ 0.05
Conversion of stock											2,700,000
Convertible Notes Payable [Member] \| Director [Member]
Debt instrument, face amount				$ 40,000
Debt instrument, maturity date				Dec. 31, 2015
Debt instrument, interest rate				10.00%
Convertible Notes Payable [Member] \| Minimum [Member]
Exercise price												0.025
Convertible Notes Payable [Member] \| Maximum [Member]
Exercise price												$ 0.07
Convertible Notes Payable [Member] \| 2016 [Member]
Proceeds from borrowings under convertible note payable									$ 160,000
Convertible Notes Payable [Member] \| January 6 [Member]
Proceeds from borrowings under convertible note payable									40,000
Convertible Notes Payable [Member] \| January 31 [Member]
Proceeds from borrowings under convertible note payable									40,000
Convertible Notes Payable [Member] \| March 7 [Member]
Proceeds from borrowings under convertible note payable									40,000
Convertible Notes Payable [Member] \| April 28 [Member]
Convertible notes payable, balance							$ 20,000		20,000
Convertible Notes Payable to Related Party [Member] \| Officer [Member]
Debt instrument, face amount	$ 10,000	$ 10,000	$ 20,000		$ 10,000	$ 10,000		$ 10,000		$ 10,000
Debt instrument, issuance date					Sep. 22, 2016	Jul. 01, 2016
Debt instrument, maturity date	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018		Dec. 31, 2016	Dec. 31, 2016
Debt instrument, interest rate	8.00%	8.00%	8.00%		10.00%	10.00%		10.00%		10.00%
Debt instrument, conversion price	$ 0.07	$ 0.07	$ 0.07		$ 0.07	$ 0.07		$ 0.07		$ 0.07
Line of credit														$ 7,000
Notes payables													$ 7,000
New Convertible Notes Payable [Member]
Debt instrument, face amount							$ 300,000		$ 300,000
Debt instrument, issuance date									May 25, 2017
Debt instrument, maturity date									Jul. 31, 2018
Debt instrument, interest rate							10.00%		10.00%
Debt instrument, conversion price							$ 0.07		$ 0.07
New Convertible Notes Payable [Member] \| June 2 [Member]
Proceeds from borrowings under convertible note payable									$ 40,000
New Convertible Notes Payable [Member] \| July 13 [Member]
Proceeds from borrowings under convertible note payable									40,000
New Convertible Notes Payable [Member] \| August 14 [Member]
Proceeds from borrowings under convertible note payable									40,000
New Convertible Notes Payable [Member] \| September 22 [Member]
Proceeds from borrowings under convertible note payable									$ 40,000
Derivative Classification [Member]
Dividend yield									0.00%
Derivative Classification [Member] \| Minimum [Member]
Expected volatility									81.33%
Risk-free interest rate									1.06%
Expected life									2 months 30 days
Derivative Classification [Member] \| Maximum [Member]
Expected volatility									118.34%
Risk-free interest rate									1.31%
Expected life									1 year 2 months 30 days
Non Convertible Notes Payable [Member]
Debt instrument, face amount												$ 51,000
Debt instrument, maturity date												Nov. 30, 2016
Debt instrument, interest rate												10.00%
Debt instrument, default rate												15.00%
Accrued interest												$ 123,797
Debt instrument, conversion price												$ 0.05
Notes receivable												$ 51,157

XML 30 R20.htm IDEA: XBRL DOCUMENT

DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) - Derivative Financial Instruments, Liabilities [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Balance	$ 76,295
Recognition of derivative liabilities upon initial valuation	162,520	40,892
Change in fair value of derivative liabilities	(112,185)	35,403
Conversions of derivative liabilities into equity instruments
Balance	$ 126,630	$ 76,295

XML 31 R21.htm IDEA: XBRL DOCUMENT

DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) - Fair Value, Measurements, Recurring [Member]	Sep. 30, 2017 USD ($)
Liabilities, fair value	$ 126,630
Derivative Financial Instruments, Liabilities [Member]
Liabilities, fair value	126,630
Level 1 [Member]
Liabilities, fair value
Level 1 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities, fair value
Level 2 [Member]
Liabilities, fair value
Level 2 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities, fair value
Level 3 [Member]
Liabilities, fair value	126,630
Level 3 [Member] \| Derivative Financial Instruments, Liabilities [Member]
Liabilities, fair value	$ 126,630

XML 32 R22.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Narrative) (Details) - USD ($)		9 Months Ended		136 Months Ended
STOCK OPTION PLANS (Narrative) (Details) - USD ($)	Aug. 24, 2015	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted during period
Option pricing assumptions
Weighted-average fair value of options granted
Stock-based compensation expense		$ 14,916	$ 25,295
Options outstanding		2,185,000		2,185,000
Unrecognized compensation cost related to employee stock options		$ 3,153
2005 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Effective term		10 years
Shares authorized		2,500,000
2005 Stock Incentive Plan [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	2,185,000
Options granted during period				3,096,000
Exercise price of stock options granted, minimum				$ 0.14
Exercise price of stock options granted, maximum				$ 2.07
Option vesting period	2 years 4 months			3 years
Option expiration period				10 years
Option pricing assumptions
Dividend yield				0.00%
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	1,960,000
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	225,000
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	640,000
Exercise price of stock options granted	$ 0.14
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	500,000
Exercise price of stock options granted	$ 0.15
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	995,000
Exercise price of stock options granted	$ 0.20
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Exercise Price Range Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of options for purchase of common shares	50,000
Exercise price of stock options granted	$ 0.25
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Minimum [Member]
Option pricing assumptions
Market value per share at time of issuance					$ 0.14
Expected term				3 years 8 months 12 days
Risk-free interest rate				1.60%
Expected volatility				200.00%
Weighted-average fair value of options granted				$ 0.16
2005 Stock Incentive Plan [Member] \| Stock Options [Member] \| Maximum [Member]
Option pricing assumptions
Market value per share at time of issuance					$ 2.07
Expected term				10 years
Risk-free interest rate				4.93%
Expected volatility				424.00%
Weighted-average fair value of options granted				$ 2.07

XML 33 R23.htm IDEA: XBRL DOCUMENT

STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details)	9 Months Ended
	Sep. 30, 2017 USD ($) $ / shares shares
Shares
Outstanding at the beginning of period \| shares	2,185,000
Granted \| shares
Expired \| shares
Forfeited \| shares
Outstanding at the end of Period \| shares	2,185,000
Exercisable at the end of the Period \| shares	1,836,667
Weighted Average Exercise Price
Outstanding at the beginning of period \| $ / shares	$ 0.16
Granted \| $ / shares
Expired \| $ / shares
Forfeited \| $ / shares
Outstanding at the end of Period \| $ / shares	0.17
Exercisable at the end of Period \| $ / shares	$ 0.17
Weighted Average Remaining Contractual Life (Years)
Outstanding at the beginning of period	8 years 7 months 28 days
Outstanding at the end of Period	7 years 10 months 28 days
Exercisable at the end of Period	7 years 10 months 28 days
Outstanding at the beginning of period \| $
Granted \| $
Expired \| $
Forfeited \| $
Outstanding at the end of Period \| $
Exercisable at the end of the Period \| $

XML 34 R24.htm IDEA: XBRL DOCUMENT

CAPITAL STOCK (Details) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
CAPITAL STOCK [Abstract]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value per share	$ 0.001	$ 0.001

XML 35 R25.htm IDEA: XBRL DOCUMENT

COMMITMENTS AND CONTINGENCIES (Details)	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Details)	Sep. 30, 2017 USD ($)
COMMITMENTS AND CONTINGENCIES [Abstract]
Operating lease expiration period	Dec. 31, 2017
Lease, monthly payment in 2015	$ 8,950
Lease, monthly payment in 2016	9,300
Lease, monthly payment in 2017	$ 9,600

XML 36 R26.htm IDEA: XBRL DOCUMENT

RELATED PARTY TRANSACTIONS (Details) - USD ($)	9 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Related Party Transaction [Line Items]
Accounts payable - related party			$ 1,420
Assumption of liabilities by related parties	54,513
Due to related parties	54,513
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Accounts payable - related party	$ 0		$ 1,420
Officer and Director [Member]
Related Party Transaction [Line Items]
Debt instrument, interest rate	8.00%
Debt instrument, conversion price	$ 0.07
Debt instrument, maturity date	Dec. 31, 2018

XML 37 R27.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details) - USD ($)	9 Months Ended		12 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($)	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2015	Nov. 09, 2017	Oct. 30, 2017	Dec. 31, 2016
Proceeds from borrowings under convertible note payable	$ 300,000	$ 380,000
Convertible Notes Payable [Member]
Annual interest rate	10.00%		10.00%			10.00%
Conversion price	$ 0.07		$ 0.05
Maturity date	Dec. 31, 2016		Dec. 31, 2016
Debt instrument, face amount	$ 300,000		$ 590,000
Accrued interest			$ 684,660
Subsequent Event [Member] \| Convertible Notes Payable [Member]
Conversion price				$ 0.05
Debt instrument, face amount				$ 160,000
Accrued interest				$ 40,000
Share issued				4,000,000
Subsequent Event [Member] \| Convertible Notes Payable [Member] \| Officer [Member]
Debt instrument, face amount					$ 20,000

EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * / var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 report.css IDEA: XBRL DOCUMENT / Updated 2009-11-04 / / v2.2.0.24 / / DefRef Styles / ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } / Report Styles / ..pl a, .pl a:visited { color: black; text-decoration: none; } / table / ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } / Top labels / ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; / word-wrap: break-word; / } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } / Header rows... / ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } / Calendars... / ..report .rc { background-color: #f0f0f0; } / Even rows... / ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } / Odd rows... / ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } / styles for footnote marker / ..report .fn { white-space: nowrap; } / styles for numeric types / ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } / styles for text types / ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 84 181 1 false 37 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://flexpoint.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://flexpoint.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://flexpoint.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://flexpoint.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://flexpoint.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 6 false false R7.htm 00000007 - Disclosure - GOING CONCERN Sheet http://flexpoint.com/role/GoingConcern GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - DERIVATIVE INSTRUMENTS Sheet http://flexpoint.com/role/DerivativeInstruments DERIVATIVE INSTRUMENTS Notes 8 false false R9.htm 00000009 - Disclosure - STOCK OPTION PLANS Sheet http://flexpoint.com/role/StockOptionPlans STOCK OPTION PLANS Notes 9 false false R10.htm 00000010 - Disclosure - CAPITAL STOCK Sheet http://flexpoint.com/role/CapitalStock CAPITAL STOCK Notes 10 false false R11.htm 00000011 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://flexpoint.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://flexpoint.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - SUBSEQUENT EVENTS Sheet http://flexpoint.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 13 false false R14.htm 00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 14 false false R15.htm 00000015 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://flexpoint.com/role/DerivativeInstrumentsTables DERIVATIVE INSTRUMENTS (Tables) Tables http://flexpoint.com/role/DerivativeInstruments 15 false false R16.htm 00000016 - Disclosure - STOCK OPTION PLANS (Tables) Sheet http://flexpoint.com/role/StockOptionPlansTables STOCK OPTION PLANS (Tables) Tables http://flexpoint.com/role/StockOptionPlans 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://flexpoint.com/role/SummaryOfSignificantAccountingPoliciesPolicies 17 false false R18.htm 00000018 - Disclosure - GOING CONCERN (Details) Sheet http://flexpoint.com/role/GoingConcernDetails GOING CONCERN (Details) Details http://flexpoint.com/role/GoingConcern 18 false false R19.htm 00000019 - Disclosure - DERIVATIVE INSTRUMENTS (Narrative) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsNarrativeDetails DERIVATIVE INSTRUMENTS (Narrative) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 19 false false R20.htm 00000020 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsScheduleOfChangesInLevel3FinancialLiabilitiesDetails DERIVATIVE INSTRUMENTS (Schedule of Changes in Level 3 Financial Liabilities) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 20 false false R21.htm 00000021 - Disclosure - DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) Sheet http://flexpoint.com/role/DerivativeInstrumentsScheduleOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails DERIVATIVE INSTRUMENTS (Schedule of Liabilities Measured at Fair Value on Recurring Basis) (Details) Details http://flexpoint.com/role/DerivativeInstrumentsTables 21 false false R22.htm 00000022 - Disclosure - STOCK OPTION PLANS (Narrative) (Details) Sheet http://flexpoint.com/role/StockOptionPlansNarrativeDetails STOCK OPTION PLANS (Narrative) (Details) Details http://flexpoint.com/role/StockOptionPlansTables 22 false false R23.htm 00000023 - Disclosure - STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Sheet http://flexpoint.com/role/StockOptionPlansScheduleOfStockOptionActivityDetails STOCK OPTION PLANS (Schedule of Stock Option Activity) (Details) Details http://flexpoint.com/role/StockOptionPlansTables 23 false false R24.htm 00000024 - Disclosure - CAPITAL STOCK (Details) Sheet http://flexpoint.com/role/CapitalStockDetails CAPITAL STOCK (Details) Details http://flexpoint.com/role/CapitalStock 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://flexpoint.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://flexpoint.com/role/CommitmentsAndContingencies 25 false false R26.htm 00000026 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://flexpoint.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://flexpoint.com/role/RelatedPartyTransactions 26 false false R27.htm 00000027 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://flexpoint.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://flexpoint.com/role/SubsequentEvents 27 false false All Reports Book All Reports flxt-20170930.xml flxt-20170930.xsd flxt-20170930_cal.xml flxt-20170930_def.xml flxt-20170930_lab.xml flxt-20170930_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 44 0001548123-17-000267-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001548123-17-000267-xbrl.zip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�XI5L3;"/"@6>:=5QD&%$BY>Z:XF"6>#P54C"R8.%B]_U$:$68\ M4W"S$[R>N9A]=18VT JXB#L3<:1=1'(AO&&TY(\(E3HR"M)/KM%%M4#1( MAX'1H?JSO3<25AN-!CY'NZ+X]6R>66B84"SW8)M7'O;$-1>_?%[S1AD1,, M Q2]$IUBD9:K&2G"8!F:4AQDM'F+_Q?_.4+]IO_#U!+ 0(4 Q0 ( )> M;DNB!D ;DNVZ4 K*0P /-L 1 " M 6]E !F;'AT+3(P,3 ;DM7!6J620P M .6/ 5 " <=Q !F;'AT+3(P,3